English
简体中文
Total: £ 56.28
Published Date: 2026-03-24 | Pages: 125 | Tables: 127 | Medical Devices & Consumables
The global Transdermal Peptide Hormone Replacement Patches market was valued at US$ 3276 million in 2025 and is anticipated to reach US$ 5452 million by 2032, at a CAGR of 7.6% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Transdermal Peptide Hormone Replacement Patches competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Transdermal peptide hormone replacement patches are advanced drug delivery systems designed to administer peptide-based hormones through the skin into systemic circulation, providing sustained and controlled release while avoiding first-pass metabolism. These patches incorporate technologies such as permeation enhancers, microneedles, iontophoresis, or matrix/reservoir systems to facilitate the delivery of large and hydrophilic peptide molecules. They are primarily used in hormone replacement therapies, including treatments for menopause, endocrine disorders, and certain metabolic conditions. From a value chain perspective, upstream includes peptide APIs, adhesive polymers, backing materials, permeation enhancers, and microfabrication components; midstream involves patch design, formulation, coating, assembly, and regulatory compliance; downstream demand comes from pharmaceutical companies, specialty clinics, hospitals, and retail pharmacies. In 2025, the average selling price is approximately US$6.50 per unit, with global demand reaching around 504 million units. The industry maintains gross margins of 45%–65%, supported by high technical barriers, regulatory complexity, and strong demand for non-invasive sustained-release therapies.
The North American market for Transdermal Peptide Hormone Replacement Patches is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for Transdermal Peptide Hormone Replacement Patches is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of Transdermal Peptide Hormone Replacement Patches include Novartis, Johnson & Johnson, Bayer, Hisamitsu Pharmaceutical, Mylan (Viatris), Teva Pharmaceutical, Luye Pharma, CSPC Pharmaceutical Group, Hainan Poly Pharm, Zhejiang Hisun Pharmaceutical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global Transdermal Peptide Hormone Replacement Patches market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Transdermal Peptide Hormone Replacement Patches. The Transdermal Peptide Hormone Replacement Patches market size, estimates, and forecasts are provided in terms of sales volume (K Pcs) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Transdermal Peptide Hormone Replacement Patches market comprehensively. Regional market sizes by Type, by Application, by Hormone Type, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Transdermal Peptide Hormone Replacement Patches manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Novartis
Johnson & Johnson
Bayer
Hisamitsu Pharmaceutical
Mylan (Viatris)
Teva Pharmaceutical
Luye Pharma
CSPC Pharmaceutical Group
Hainan Poly Pharm
Zhejiang Hisun Pharmaceutical
3M Drug Delivery Systems
LTS Lohmann Therapie-Systeme
Nitto Denko
Scapa Healthcare
Segment by Type
Matrix Patch
Reservoir Patch
Drug-in-Adhesive Patch
Segment by Hormone Type
Peptide Hormones
Protein Hormones
Combination Hormone Systems
Segment by Delivery Technology
Passive Diffusion
Microneedle-assisted
Iontophoresis
Ultrasound-enhanced
by Application
Hospitals
Specialty Clinics
Homecare Patients
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Hormone Type, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Transdermal Peptide Hormone Replacement Patches manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Transdermal Peptide Hormone Replacement Patches sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Transdermal Peptide Hormone Replacement Patches Market Overview
1.1 Product Definition
1.2 Transdermal Peptide Hormone Replacement Patches by Type
1.2.1 Global Transdermal Peptide Hormone Replacement Patches Market Value by Type: 2025 vs 2032
1.2.2 Matrix Patch
1.2.3 Reservoir Patch
1.2.4 Drug-in-Adhesive Patch
1.3 Transdermal Peptide Hormone Replacement Patches by Hormone Type
1.3.1 Global Transdermal Peptide Hormone Replacement Patches Market Value by Hormone Type: 2025 vs 2032
1.3.2 Peptide Hormones
1.3.3 Protein Hormones
1.3.4 Combination Hormone Systems
1.4 Transdermal Peptide Hormone Replacement Patches by Delivery Technology
1.4.1 Global Transdermal Peptide Hormone Replacement Patches Market Value by Delivery Technology: 2025 vs 2032
1.4.2 Passive Diffusion
1.4.3 Microneedle-assisted
1.4.4 Iontophoresis
1.4.5 Ultrasound-enhanced
1.5 Transdermal Peptide Hormone Replacement Patches by Application
1.5.1 Global Transdermal Peptide Hormone Replacement Patches Market Value by Application: 2025 vs 2032
1.5.2 Hospitals
1.5.3 Specialty Clinics
1.5.4 Homecare Patients
1.6 Global Transdermal Peptide Hormone Replacement Patches Market Size Estimates and Forecasts
1.6.1 Global Transdermal Peptide Hormone Replacement Patches Revenue 2021–2032
1.6.2 Global Transdermal Peptide Hormone Replacement Patches Sales 2021–2032
1.6.3 Global Transdermal Peptide Hormone Replacement Patches Market Average Price (2021–2032)
1.7 Assumptions and Limitations
2 Transdermal Peptide Hormone Replacement Patches Market Competition by Manufacturers
2.1 Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Manufacturers (2021–2026)
2.2 Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Transdermal Peptide Hormone Replacement Patches Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Transdermal Peptide Hormone Replacement Patches, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Transdermal Peptide Hormone Replacement Patches, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Transdermal Peptide Hormone Replacement Patches, Product Types and Applications
2.7 Global Key Manufacturers of Transdermal Peptide Hormone Replacement Patches, Date of Entry into the Industry
2.8 Global Transdermal Peptide Hormone Replacement Patches Market Competitive Situation and Trends
2.8.1 Global Transdermal Peptide Hormone Replacement Patches Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Transdermal Peptide Hormone Replacement Patches Players Market Share by Revenue
2.8.3 Global Transdermal Peptide Hormone Replacement Patches Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Transdermal Peptide Hormone Replacement Patches Market Scenario by Region
3.1 Global Transdermal Peptide Hormone Replacement Patches Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Transdermal Peptide Hormone Replacement Patches Sales by Region: 2021–2032
3.2.1 Global Transdermal Peptide Hormone Replacement Patches Sales by Region: 2021–2026
3.2.2 Global Transdermal Peptide Hormone Replacement Patches Sales by Region: 2027–2032
3.3 Global Transdermal Peptide Hormone Replacement Patches Revenue by Region: 2021–2032
3.3.1 Global Transdermal Peptide Hormone Replacement Patches Revenue by Region: 2021–2026
3.3.2 Global Transdermal Peptide Hormone Replacement Patches Revenue by Region: 2027–2032
3.4 North America Transdermal Peptide Hormone Replacement Patches Market Facts & Figures by Country
3.4.1 North America Transdermal Peptide Hormone Replacement Patches Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Transdermal Peptide Hormone Replacement Patches Sales by Country (2021–2032)
3.4.3 North America Transdermal Peptide Hormone Replacement Patches Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Transdermal Peptide Hormone Replacement Patches Market Facts & Figures by Country
3.5.1 Europe Transdermal Peptide Hormone Replacement Patches Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Transdermal Peptide Hormone Replacement Patches Sales by Country (2021–2032)
3.5.3 Europe Transdermal Peptide Hormone Replacement Patches Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transdermal Peptide Hormone Replacement Patches Market Facts & Figures by Region
3.6.1 Asia Pacific Transdermal Peptide Hormone Replacement Patches Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Transdermal Peptide Hormone Replacement Patches Sales by Region (2021–2032)
3.6.3 Asia Pacific Transdermal Peptide Hormone Replacement Patches Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Transdermal Peptide Hormone Replacement Patches Market Facts & Figures by Country
3.7.1 Latin America Transdermal Peptide Hormone Replacement Patches Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Transdermal Peptide Hormone Replacement Patches Sales by Country (2021–2032)
3.7.3 Latin America Transdermal Peptide Hormone Replacement Patches Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Transdermal Peptide Hormone Replacement Patches Market Facts & Figures by Country
3.8.1 Middle East and Africa Transdermal Peptide Hormone Replacement Patches Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Transdermal Peptide Hormone Replacement Patches Sales by Country (2021–2032)
3.8.3 Middle East and Africa Transdermal Peptide Hormone Replacement Patches Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Transdermal Peptide Hormone Replacement Patches Sales by Type (2021–2032)
4.1.1 Global Transdermal Peptide Hormone Replacement Patches Sales by Type (2021–2026)
4.1.2 Global Transdermal Peptide Hormone Replacement Patches Sales by Type (2027–2032)
4.1.3 Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Type (2021–2032)
4.2 Global Transdermal Peptide Hormone Replacement Patches Revenue by Type (2021–2032)
4.2.1 Global Transdermal Peptide Hormone Replacement Patches Revenue by Type (2021–2026)
4.2.2 Global Transdermal Peptide Hormone Replacement Patches Revenue by Type (2027–2032)
4.2.3 Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Type (2021–2032)
4.3 Global Transdermal Peptide Hormone Replacement Patches Price by Type (2021–2032)
5 Segment by Application
5.1 Global Transdermal Peptide Hormone Replacement Patches Sales by Application (2021–2032)
5.1.1 Global Transdermal Peptide Hormone Replacement Patches Sales by Application (2021–2026)
5.1.2 Global Transdermal Peptide Hormone Replacement Patches Sales by Application (2027–2032)
5.1.3 Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Application (2021–2032)
5.2 Global Transdermal Peptide Hormone Replacement Patches Revenue by Application (2021–2032)
5.2.1 Global Transdermal Peptide Hormone Replacement Patches Revenue by Application (2021–2026)
5.2.2 Global Transdermal Peptide Hormone Replacement Patches Revenue by Application (2027–2032)
5.2.3 Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Application (2021–2032)
5.3 Global Transdermal Peptide Hormone Replacement Patches Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Novartis
6.1.1 Novartis Company Information
6.1.2 Novartis Description and Business Overview
6.1.3 Novartis Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Novartis Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.1.5 Novartis Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Johnson & Johnson Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bayer Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 Hisamitsu Pharmaceutical
6.4.1 Hisamitsu Pharmaceutical Company Information
6.4.2 Hisamitsu Pharmaceutical Description and Business Overview
6.4.3 Hisamitsu Pharmaceutical Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Hisamitsu Pharmaceutical Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.4.5 Hisamitsu Pharmaceutical Recent Developments/Updates
6.5 Mylan (Viatris)
6.5.1 Mylan (Viatris) Company Information
6.5.2 Mylan (Viatris) Description and Business Overview
6.5.3 Mylan (Viatris) Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Mylan (Viatris) Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.5.5 Mylan (Viatris) Recent Developments/Updates
6.6 Teva Pharmaceutical
6.6.1 Teva Pharmaceutical Company Information
6.6.2 Teva Pharmaceutical Description and Business Overview
6.6.3 Teva Pharmaceutical Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Teva Pharmaceutical Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.6.5 Teva Pharmaceutical Recent Developments/Updates
6.7 Luye Pharma
6.7.1 Luye Pharma Company Information
6.7.2 Luye Pharma Description and Business Overview
6.7.3 Luye Pharma Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Luye Pharma Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.7.5 Luye Pharma Recent Developments/Updates
6.8 CSPC Pharmaceutical Group
6.8.1 CSPC Pharmaceutical Group Company Information
6.8.2 CSPC Pharmaceutical Group Description and Business Overview
6.8.3 CSPC Pharmaceutical Group Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 CSPC Pharmaceutical Group Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.8.5 CSPC Pharmaceutical Group Recent Developments/Updates
6.9 Hainan Poly Pharm
6.9.1 Hainan Poly Pharm Company Information
6.9.2 Hainan Poly Pharm Description and Business Overview
6.9.3 Hainan Poly Pharm Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hainan Poly Pharm Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.9.5 Hainan Poly Pharm Recent Developments/Updates
6.10 Zhejiang Hisun Pharmaceutical
6.10.1 Zhejiang Hisun Pharmaceutical Company Information
6.10.2 Zhejiang Hisun Pharmaceutical Description and Business Overview
6.10.3 Zhejiang Hisun Pharmaceutical Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Zhejiang Hisun Pharmaceutical Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.10.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
6.11 3M Drug Delivery Systems
6.11.1 3M Drug Delivery Systems Company Information
6.11.2 3M Drug Delivery Systems Description and Business Overview
6.11.3 3M Drug Delivery Systems Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 3M Drug Delivery Systems Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.11.5 3M Drug Delivery Systems Recent Developments/Updates
6.12 LTS Lohmann Therapie-Systeme
6.12.1 LTS Lohmann Therapie-Systeme Company Information
6.12.2 LTS Lohmann Therapie-Systeme Description and Business Overview
6.12.3 LTS Lohmann Therapie-Systeme Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 LTS Lohmann Therapie-Systeme Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.12.5 LTS Lohmann Therapie-Systeme Recent Developments/Updates
6.13 Nitto Denko
6.13.1 Nitto Denko Company Information
6.13.2 Nitto Denko Description and Business Overview
6.13.3 Nitto Denko Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Nitto Denko Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.13.5 Nitto Denko Recent Developments/Updates
6.14 Scapa Healthcare
6.14.1 Scapa Healthcare Company Information
6.14.2 Scapa Healthcare Description and Business Overview
6.14.3 Scapa Healthcare Transdermal Peptide Hormone Replacement Patches Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Scapa Healthcare Transdermal Peptide Hormone Replacement Patches Product Portfolio
6.14.5 Scapa Healthcare Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transdermal Peptide Hormone Replacement Patches Industry Chain Analysis
7.2 Transdermal Peptide Hormone Replacement Patches Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transdermal Peptide Hormone Replacement Patches Production Mode & Process Analysis
7.4 Transdermal Peptide Hormone Replacement Patches Sales and Marketing
7.4.1 Transdermal Peptide Hormone Replacement Patches Sales Channels
7.4.2 Transdermal Peptide Hormone Replacement Patches Distributors
7.5 Transdermal Peptide Hormone Replacement Patches Customer Analysis
8 Transdermal Peptide Hormone Replacement Patches Market Dynamics
8.1 Transdermal Peptide Hormone Replacement Patches Industry Trends
8.2 Transdermal Peptide Hormone Replacement Patches Market Drivers
8.3 Transdermal Peptide Hormone Replacement Patches Market Challenges
8.4 Transdermal Peptide Hormone Replacement Patches Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Transdermal Peptide Hormone Replacement Patches Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Transdermal Peptide Hormone Replacement Patches Market Value by Hormone Type (US$ Million), 2025 vs 2032
Table 3. Global Transdermal Peptide Hormone Replacement Patches Market Value by Delivery Technology (US$ Million), 2025 vs 2032
Table 4. Global Transdermal Peptide Hormone Replacement Patches Market Value by Application (US$ Million), 2025 vs 2032
Table 5. Global Transdermal Peptide Hormone Replacement Patches Market Competitive Situation by Manufacturers in 2025
Table 6. Global Transdermal Peptide Hormone Replacement Patches Sales (K Pcs) of Key Manufacturers (2021–2026)
Table 7. Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Manufacturers (2021–2026)
Table 8. Global Transdermal Peptide Hormone Replacement Patches Revenue (US$ Million) by Manufacturers (2021–2026)
Table 9. Global Transdermal Peptide Hormone Replacement Patches Revenue Share by Manufacturers (2021–2026)
Table 10. Global Market Transdermal Peptide Hormone Replacement Patches Average Price (US$/Pc) of Key Manufacturers (2021–2026)
Table 11. Global Key Players of Transdermal Peptide Hormone Replacement Patches, Industry Ranking, 2023 vs 2024 vs 2025
Table 12. Global Key Manufacturers of Transdermal Peptide Hormone Replacement Patches, Manufacturing Sites and Headquarters
Table 13. Global Key Manufacturers of Transdermal Peptide Hormone Replacement Patches, Product Types and Applications
Table 14. Global Key Manufacturers of Transdermal Peptide Hormone Replacement Patches, Date of Entry into the Industry
Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 16. Global Transdermal Peptide Hormone Replacement Patches Companies by Tier (Tier 1, Tier 2, Tier 3), based on Transdermal Peptide Hormone Replacement Patches Revenue, 2025
Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 18. Global Transdermal Peptide Hormone Replacement Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Transdermal Peptide Hormone Replacement Patches Sales by Region (K Pcs), 2021–2026
Table 20. Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Region (2021–2026)
Table 21. Global Transdermal Peptide Hormone Replacement Patches Sales by Region (K Pcs), 2027–2032
Table 22. Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Region (2027–2032)
Table 23. Global Transdermal Peptide Hormone Replacement Patches Revenue by Region (US$ Million), 2021–2026
Table 24. Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Region (2021–2026)
Table 25. Global Transdermal Peptide Hormone Replacement Patches Revenue by Region (US$ Million), 2027–2032
Table 26. Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Region (2027–2032)
Table 27. North America Transdermal Peptide Hormone Replacement Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 28. North America Transdermal Peptide Hormone Replacement Patches Sales by Country (K Pcs), 2021–2026
Table 29. North America Transdermal Peptide Hormone Replacement Patches Sales by Country (K Pcs), 2027–2032
Table 30. North America Transdermal Peptide Hormone Replacement Patches Revenue by Country (US$ Million), 2021–2026
Table 31. North America Transdermal Peptide Hormone Replacement Patches Revenue by Country (US$ Million), 2027–2032
Table 32. Europe Transdermal Peptide Hormone Replacement Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 33. Europe Transdermal Peptide Hormone Replacement Patches Sales by Country (K Pcs), 2021–2026
Table 34. Europe Transdermal Peptide Hormone Replacement Patches Sales by Country (K Pcs), 2027–2032
Table 35. Europe Transdermal Peptide Hormone Replacement Patches Revenue by Country (US$ Million), 2021–2026
Table 36. Europe Transdermal Peptide Hormone Replacement Patches Revenue by Country (US$ Million), 2027–2032
Table 37. Asia Pacific Transdermal Peptide Hormone Replacement Patches Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 38. Asia Pacific Transdermal Peptide Hormone Replacement Patches Sales by Region (K Pcs), 2021–2026
Table 39. Asia Pacific Transdermal Peptide Hormone Replacement Patches Sales by Region (K Pcs), 2027–2032
Table 40. Asia Pacific Transdermal Peptide Hormone Replacement Patches Revenue by Region (US$ Million), 2021–2026
Table 41. Asia Pacific Transdermal Peptide Hormone Replacement Patches Revenue by Region (US$ Million), 2027–2032
Table 42. Latin America Transdermal Peptide Hormone Replacement Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 43. Latin America Transdermal Peptide Hormone Replacement Patches Sales by Country (K Pcs), 2021–2026
Table 44. Latin America Transdermal Peptide Hormone Replacement Patches Sales by Country (K Pcs), 2027–2032
Table 45. Latin America Transdermal Peptide Hormone Replacement Patches Revenue by Country (US$ Million), 2021–2026
Table 46. Latin America Transdermal Peptide Hormone Replacement Patches Revenue by Country (US$ Million), 2027–2032
Table 47. Middle East and Africa Transdermal Peptide Hormone Replacement Patches Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 48. Middle East and Africa Transdermal Peptide Hormone Replacement Patches Sales by Country (K Pcs), 2021–2026
Table 49. Middle East and Africa Transdermal Peptide Hormone Replacement Patches Sales by Country (K Pcs), 2027–2032
Table 50. Middle East and Africa Transdermal Peptide Hormone Replacement Patches Revenue by Country (US$ Million), 2021–2026
Table 51. Middle East and Africa Transdermal Peptide Hormone Replacement Patches Revenue by Country (US$ Million), 2027–2032
Table 52. Global Transdermal Peptide Hormone Replacement Patches Sales (K Pcs) by Type (2021–2026)
Table 53. Global Transdermal Peptide Hormone Replacement Patches Sales (K Pcs) by Type (2027–2032)
Table 54. Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Type (2021–2026)
Table 55. Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Type (2027–2032)
Table 56. Global Transdermal Peptide Hormone Replacement Patches Revenue (US$ Million) by Type (2021–2026)
Table 57. Global Transdermal Peptide Hormone Replacement Patches Revenue (US$ Million) by Type (2027–2032)
Table 58. Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Type (2021–2026)
Table 59. Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Type (2027–2032)
Table 60. Global Transdermal Peptide Hormone Replacement Patches Price (US$/Pc) by Type (2021–2026)
Table 61. Global Transdermal Peptide Hormone Replacement Patches Price (US$/Pc) by Type (2027–2032)
Table 62. Global Transdermal Peptide Hormone Replacement Patches Sales (K Pcs) by Application (2021–2026)
Table 63. Global Transdermal Peptide Hormone Replacement Patches Sales (K Pcs) by Application (2027–2032)
Table 64. Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Application (2021–2026)
Table 65. Global Transdermal Peptide Hormone Replacement Patches Sales Market Share by Application (2027–2032)
Table 66. Global Transdermal Peptide Hormone Replacement Patches Revenue (US$ Million) by Application (2021–2026)
Table 67. Global Transdermal Peptide Hormone Replacement Patches Revenue (US$ Million) by Application (2027–2032)
Table 68. Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Application (2021–2026)
Table 69. Global Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Application (2027–2032)
Table 70. Global Transdermal Peptide Hormone Replacement Patches Price (US$/Pc) by Application (2021–2026)
Table 71. Global Transdermal Peptide Hormone Replacement Patches Price (US$/Pc) by Application (2027–2032)
Table 72. Novartis Company Information
Table 73. Novartis Description and Business Overview
Table 74. Novartis Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 75. Novartis Transdermal Peptide Hormone Replacement Patches Product
Table 76. Novartis Recent Developments/Updates
Table 77. Johnson & Johnson Company Information
Table 78. Johnson & Johnson Description and Business Overview
Table 79. Johnson & Johnson Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 80. Johnson & Johnson Transdermal Peptide Hormone Replacement Patches Product
Table 81. Johnson & Johnson Recent Developments/Updates
Table 82. Bayer Company Information
Table 83. Bayer Description and Business Overview
Table 84. Bayer Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 85. Bayer Transdermal Peptide Hormone Replacement Patches Product
Table 86. Bayer Recent Developments/Updates
Table 87. Hisamitsu Pharmaceutical Company Information
Table 88. Hisamitsu Pharmaceutical Description and Business Overview
Table 89. Hisamitsu Pharmaceutical Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 90. Hisamitsu Pharmaceutical Transdermal Peptide Hormone Replacement Patches Product
Table 91. Hisamitsu Pharmaceutical Recent Developments/Updates
Table 92. Mylan (Viatris) Company Information
Table 93. Mylan (Viatris) Description and Business Overview
Table 94. Mylan (Viatris) Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 95. Mylan (Viatris) Transdermal Peptide Hormone Replacement Patches Product
Table 96. Mylan (Viatris) Recent Developments/Updates
Table 97. Teva Pharmaceutical Company Information
Table 98. Teva Pharmaceutical Description and Business Overview
Table 99. Teva Pharmaceutical Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 100. Teva Pharmaceutical Transdermal Peptide Hormone Replacement Patches Product
Table 101. Teva Pharmaceutical Recent Developments/Updates
Table 102. Luye Pharma Company Information
Table 103. Luye Pharma Description and Business Overview
Table 104. Luye Pharma Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 105. Luye Pharma Transdermal Peptide Hormone Replacement Patches Product
Table 106. Luye Pharma Recent Developments/Updates
Table 107. CSPC Pharmaceutical Group Company Information
Table 108. CSPC Pharmaceutical Group Description and Business Overview
Table 109. CSPC Pharmaceutical Group Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 110. CSPC Pharmaceutical Group Transdermal Peptide Hormone Replacement Patches Product
Table 111. CSPC Pharmaceutical Group Recent Developments/Updates
Table 112. Hainan Poly Pharm Company Information
Table 113. Hainan Poly Pharm Description and Business Overview
Table 114. Hainan Poly Pharm Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 115. Hainan Poly Pharm Transdermal Peptide Hormone Replacement Patches Product
Table 116. Hainan Poly Pharm Recent Developments/Updates
Table 117. Zhejiang Hisun Pharmaceutical Company Information
Table 118. Zhejiang Hisun Pharmaceutical Description and Business Overview
Table 119. Zhejiang Hisun Pharmaceutical Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 120. Zhejiang Hisun Pharmaceutical Transdermal Peptide Hormone Replacement Patches Product
Table 121. Zhejiang Hisun Pharmaceutical Recent Developments/Updates
Table 122. 3M Drug Delivery Systems Company Information
Table 123. 3M Drug Delivery Systems Description and Business Overview
Table 124. 3M Drug Delivery Systems Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 125. 3M Drug Delivery Systems Transdermal Peptide Hormone Replacement Patches Product
Table 126. 3M Drug Delivery Systems Recent Developments/Updates
Table 127. LTS Lohmann Therapie-Systeme Company Information
Table 128. LTS Lohmann Therapie-Systeme Description and Business Overview
Table 129. LTS Lohmann Therapie-Systeme Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 130. LTS Lohmann Therapie-Systeme Transdermal Peptide Hormone Replacement Patches Product
Table 131. LTS Lohmann Therapie-Systeme Recent Developments/Updates
Table 132. Nitto Denko Company Information
Table 133. Nitto Denko Description and Business Overview
Table 134. Nitto Denko Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 135. Nitto Denko Transdermal Peptide Hormone Replacement Patches Product
Table 136. Nitto Denko Recent Developments/Updates
Table 137. Scapa Healthcare Company Information
Table 138. Scapa Healthcare Description and Business Overview
Table 139. Scapa Healthcare Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), Revenue (US$ Million), Price (US$/Pc), and Gross Margin (2021–2026)
Table 140. Scapa Healthcare Transdermal Peptide Hormone Replacement Patches Product
Table 141. Scapa Healthcare Recent Developments/Updates
Table 142. Key Raw Materials Lists
Table 143. Raw Materials Key Suppliers Lists
Table 144. Transdermal Peptide Hormone Replacement Patches Distributors List
Table 145. Transdermal Peptide Hormone Replacement Patches Customers List
Table 146. Transdermal Peptide Hormone Replacement Patches Market Trends
Table 147. Transdermal Peptide Hormone Replacement Patches Market Drivers
Table 148. Transdermal Peptide Hormone Replacement Patches Market Challenges
Table 149. Transdermal Peptide Hormone Replacement Patches Market Restraints
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
Table 153. Authors List of This Report
List of Figures
Figure 1. Product Picture of Transdermal Peptide Hormone Replacement Patches
Figure 2. Global Transdermal Peptide Hormone Replacement Patches Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Transdermal Peptide Hormone Replacement Patches Market Share by Type: 2025 & 2032
Figure 4. Matrix Patch Product Picture
Figure 5. Reservoir Patch Product Picture
Figure 6. Drug-in-Adhesive Patch Product Picture
Figure 7. Global Transdermal Peptide Hormone Replacement Patches Market Value by Hormone Type (US$ Million), 2021–2032
Figure 8. Global Transdermal Peptide Hormone Replacement Patches Market Share by Hormone Type: 2025 vs 2032
Figure 9. Peptide Hormones Product Picture
Figure 10. Protein Hormones Product Picture
Figure 11. Combination Hormone Systems Product Picture
Figure 12. Global Transdermal Peptide Hormone Replacement Patches Market Value by Delivery Technology (US$ Million), 2021–2032
Figure 13. Global Transdermal Peptide Hormone Replacement Patches Market Share by Delivery Technology: 2025 vs 2032
Figure 14. Passive Diffusion Product Picture
Figure 15. Microneedle-assisted Product Picture
Figure 16. Iontophoresis Product Picture
Figure 17. Ultrasound-enhanced Product Picture
Figure 18. Global Transdermal Peptide Hormone Replacement Patches Market Value by Application (US$ Million), 2021–2032
Figure 19. Global Transdermal Peptide Hormone Replacement Patches Market Share by Application: 2025 & 2032
Figure 20. Hospitals
Figure 21. Specialty Clinics
Figure 22. Homecare Patients
Figure 23. Global Transdermal Peptide Hormone Replacement Patches Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 24. Global Transdermal Peptide Hormone Replacement Patches Market Size (US$ Million), 2021–2032
Figure 25. Global Transdermal Peptide Hormone Replacement Patches Sales (K Pcs), 2021–2032
Figure 26. Global Transdermal Peptide Hormone Replacement Patches Average Price (US$/Pc), 2021–2032
Figure 27. Transdermal Peptide Hormone Replacement Patches Report Years Considered
Figure 28. Transdermal Peptide Hormone Replacement Patches Sales Share by Manufacturers in 2025
Figure 29. Global Transdermal Peptide Hormone Replacement Patches Revenue Share by Manufacturers in 2025
Figure 30. Top 5 and Top 10 Global Transdermal Peptide Hormone Replacement Patches Players: Market Share by Revenue in Transdermal Peptide Hormone Replacement Patches in 2025
Figure 31. Transdermal Peptide Hormone Replacement Patches Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 32. Global Transdermal Peptide Hormone Replacement Patches Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 33. North America Transdermal Peptide Hormone Replacement Patches Sales Market Share by Country (2021–2032)
Figure 34. North America Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Country (2021–2032)
Figure 35. United States Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Canada Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Europe Transdermal Peptide Hormone Replacement Patches Sales Market Share by Country (2021–2032)
Figure 38. Europe Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Country (2021–2032)
Figure 39. Germany Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. France Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. U.K. Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Italy Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Russia Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 44. Asia Pacific Transdermal Peptide Hormone Replacement Patches Sales Market Share by Region (2021–2032)
Figure 45. Asia Pacific Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Region (2021–2032)
Figure 46. China Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Japan Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. South Korea Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. India Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 50. Australia Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. China Taiwan Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Southeast Asia Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Latin America Transdermal Peptide Hormone Replacement Patches Sales Market Share by Country (2021–2032)
Figure 54. Latin America Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Country (2021–2032)
Figure 55. Mexico Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 56. Brazil Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 57. Argentina Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 58. Colombia Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 59. Middle East and Africa Transdermal Peptide Hormone Replacement Patches Sales Market Share by Country (2021–2032)
Figure 60. Middle East and Africa Transdermal Peptide Hormone Replacement Patches Revenue Market Share by Country (2021–2032)
Figure 61. Turkey Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 62. Saudi Arabia Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 63. UAE Transdermal Peptide Hormone Replacement Patches Revenue Growth Rate (US$ Million), 2021–2032
Figure 64. Global Sales Market Share of Transdermal Peptide Hormone Replacement Patches by Type (2021–2032)
Figure 65. Global Revenue Market Share of Transdermal Peptide Hormone Replacement Patches by Type (2021–2032)
Figure 66. Global Transdermal Peptide Hormone Replacement Patches Price (US$/Pc) by Type (2021–2032)
Figure 67. Global Sales Market Share of Transdermal Peptide Hormone Replacement Patches by Application (2021–2032)
Figure 68. Global Revenue Market Share of Transdermal Peptide Hormone Replacement Patches by Application (2021–2032)
Figure 69. Global Transdermal Peptide Hormone Replacement Patches Price (US$/Pc) by Application (2021–2032)
Figure 70. Transdermal Peptide Hormone Replacement Patches Value Chain
Figure 71. Channels of Distribution (Direct Vs Distribution)
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
